BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2
Authors
Keywords
-
Journal
NATURE IMMUNOLOGY
Volume 23, Issue 1, Pages 33-39
Publisher
Springer Science and Business Media LLC
Online
2021-12-01
DOI
10.1038/s41590-021-01088-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
- (2021) Priyanka Shah et al. Frontiers in Immunology
- Integrated analysis of multimodal single-cell data
- (2021) Yuhan Hao et al. CELL
- SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
- (2021) Fatima Amanat et al. CELL
- Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19
- (2021) Alexis J. Combes et al. NATURE
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- Publisher Correction: Dysregulation of brain and choroid plexus cell types in severe COVID-19
- (2021) Andrew C. Yang et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- (2020) Christoph Kreer et al. CELL
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19
- (2020) Aaron J. Wilk et al. NATURE MEDICINE
- Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans
- (2020) Ali H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Human germinal centres engage memory and naive B cells after influenza vaccination
- (2020) Jackson S. Turner et al. NATURE
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
- (2020) Katlyn Lederer et al. IMMUNITY
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans
- (2020) Haley L. Dugan et al. Science Translational Medicine
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- The Maintenance of Memory Plasma Cells
- (2019) Laleh Khodadadi et al. Frontiers in Immunology
- Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
- (2019) Anna-Karin E. Palm et al. Frontiers in Immunology
- Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
- (2019) Ignacio Sanz et al. Frontiers in Immunology
- Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
- (2018) Robert K. Abbott et al. IMMUNITY
- Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction
- (2018) Xin Li et al. IMMUNITY
- Dimensionality reduction for visualizing single-cell data using UMAP
- (2018) Etienne Becht et al. NATURE BIOTECHNOLOGY
- A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells
- (2016) Florian J. Weisel et al. IMMUNITY
- CD83 Modulates B Cell Activation and Germinal Center Responses
- (2016) Lena Krzyzak et al. JOURNAL OF IMMUNOLOGY
- CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype
- (2014) Griselda V Zuccarino-Catania et al. NATURE IMMUNOLOGY
- Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand
- (2014) Mohan S. Maddur et al. Nature Communications
- What Is and What Should Always Have Been: Long-Lived Plasma Cells Induced by T Cell-Independent Antigens
- (2013) A. Bortnick et al. JOURNAL OF IMMUNOLOGY
- Origin and Function of Circulating Plasmablasts during Acute Viral Infections
- (2012) Katja Fink Frontiers in Immunology
- Blood-borne human plasma cells in steady state are derived from mucosal immune responses
- (2008) H. E. Mei et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started